Large cap drug and biotech stocks sold off as buyers favor technology. Within the NASDAQ-100 up 1% led by GOOG, BIDU and SIRI. Alexion (ALXN $52.19) bucked the weakness in biotech up 1.74% but GILD, ILMN and AMGN down. Some major rotation going on today out of healthcare and into energy ( up 1.8%) and internet stocks The Petrohawk (HK) up 63% acquisition by BHP was the catalyst for nat gas stocks .Shale net gas assets look good. Next week will be big for financial reporting and news on the debt ceiling.
Mid cap biotechs were listless but there were a few big winners like ARIA up 3.3%, Exelixis (EXEL) up 2.6% and VICL up 7% . Seattle Genetics(SGEN) sold off on news after favorable panel review but concern voiced by some analysts.
The Rayno Life Science Portfolio was down 0.38% with Alexion (ALXN) the big winner and Seattle Genetics (SGEN ) the big loser. Tools and diagnostics were flat to weak.